Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
CC transcript
Asset disposition
|
|
ARIAD PHARMACEUTICALS INC (ARIA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2016 |
8-K
| Form 8-K - Current report |
| 06/02/2016 |
8-K
| Form 8-K - Current report |
| 06/17/2014 |
8-K
| Asset disposition|
Docs:
|
"Indenture, by and between ARIAD Pharmaceuticals, Inc. and Wells Fargo Bank, National Association, as trustee",
"Purchase Agreement, by and between ARIAD Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, as representative of the initial purchasers named therein",
"Convertible Note Hedge Confirmation, by and between ARIAD Pharmaceuticals, Inc. and JPMorgan Chase Bank, National Association",
"Warrant Confirmation , by and between ARIAD Pharmaceuticals, Inc. and JPMorgan Chase Bank, National Association",
"ARIAD ANNOUNCES PROPOSED $175 MILLION OFFERING OF CONVERTIBLE SENIOR NOTES DUE 2019",
"ARIAD ANNOUNCES PRICING OF $200 MILLION OFFERING OF 3.625% CONVERTIBLE SENIOR NOTES DUE 2019" |
|
| 11/02/2006 |
8-K
| Form 8-K - Current report |
|
|